February 11th 2021 Drug delivery with bioadhesive nanoparticles shows exceptional promise. One in five people in the U.S. will develop skin cancer in their lifetime, with the most common type of malignant skin cancer, squamous cell carcinoma or SCC, killing 10,000 people each year1,2. Cases of skin cancer are steadily rising, and in fact, skin … Continue reading Research with mice paves the way for injectable skin cancer treatment